Focused Alpha’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$645K Buy
2,900
+175
+6% +$40.7K 0.16% 119
2026
Q2
$647K Buy
2,725
+29
+1% +$6.03K 0.17% 119
2026
Q1
$570K Sell
2,696
-5
-0.2% -$1.08K 0.18% 120
2025
Q4
$555K Buy
+2,701
New +$508K 0.16% 130

Other funds holding CAH

Focused Alpha's CAH Position: Q3 2026 in Review

Focused Alpha increased its Cardinal Health (CAH) stake by 6.4% in Q3 2026, buying an estimated $40.7K and bringing the position to 2,900 shares worth $645K. The position accounts for 0.16% of the portfolio, ranked #119.

Focused Alpha first reported a position in CAH in Q4 2025 and has held it in 4 quarters since. The position peaked at $647K in Q2 2026. 1,272 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Focused Alpha held 2,900 shares of Cardinal Health worth $645K as of Q3 2026.
  • Focused Alpha bought 175 Cardinal Health shares in Q3 2026, an estimated $40.7K.
  • Cardinal Health made up 0.16% of Focused Alpha's portfolio in Q3 2026, its #119 holding.
  • Focused Alpha first reported a position in Cardinal Health in Q4 2025 and has held it in 4 quarters since.
  • Focused Alpha's Cardinal Health position peaked at $647K in Q2 2026.
  • 1,272 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.